BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22393910)

  • 1. Corticosteroid-induced osteoporosis: an update for dermatologists.
    Clarke BL
    Am J Clin Dermatol; 2012 Jun; 13(3):167-90. PubMed ID: 22393910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and glucocorticoids.
    Briot K
    Ann Endocrinol (Paris); 2018 Jun; 79(3):115-118. PubMed ID: 29685453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current indications for prevention and therapy of steroid-induced osteoporosis in men and women].
    Sewerynek E
    Endokrynol Pol; 2011; 62 Suppl 2():1-8. PubMed ID: 22125016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
    Buxton EC; Yao W; Lane NE
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3332-6. PubMed ID: 15240611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticosteroid-induced osteoporosis].
    Briot K; Roux C
    Rev Med Interne; 2013 May; 34(5):315-23. PubMed ID: 23238181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
    Chotiyarnwong P; McCloskey EV
    Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
    Canalis E; Mazziotti G; Giustina A; Bilezikian JP
    Osteoporos Int; 2007 Oct; 18(10):1319-28. PubMed ID: 17566815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
    Hofbauer LC; Gori F; Riggs BL; Lacey DL; Dunstan CR; Spelsberg TC; Khosla S
    Endocrinology; 1999 Oct; 140(10):4382-9. PubMed ID: 10499489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of glucocorticoid action in bone.
    Canalis E; Delany AM
    Ann N Y Acad Sci; 2002 Jun; 966():73-81. PubMed ID: 12114261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid osteoporosis.
    Sambrook P; Lane NE
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):401-13. PubMed ID: 11485337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.